Testing a New Way to Precisely Target and Predict the Impact of TMS Brain Stimulation for Depression
As non-invasive brain stimulation—variations of TMS (transcranial magnetic stimulation)—continues to evolve and is administered to a growing number of patients with depression (and other illnesses,…
Read More
Researchers say they have identified an objective biomarker of recovery in major depression that in a small cohort of treatment-resistant patients was able (on an ongoing basis) to capture whether…
Read More
In their efforts to understand the beneficial effects of SAINT, an important new fast-acting brain stimulation treatment for refractory major depression, researchers now think they understand why it…
Read More
Over the last decade, rTMS (repetitive transcranial magnetic stimulation), a form of non-invasive brain stimulation, has become a first-line treatment option for depressed patients, including those…
Read More
In its first randomized, placebo-controlled test, an enhanced form of non-invasive brain stimulation called SNT (Stanford Neuromodulation Therapy, formerly called SAINT) generated "a large…
Read More
